Home › Funds › Royce & Associates › SRTA
Royce & Associates position in SRTA
STRATA CRITICAL MEDICAL INC · Health Care
Latest position (Q2 2026)3.13M sh
Reported value held$16.51M
Portfolio Weight0.13%
First reportedQ4 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 492.00K | $2.09M | New |
| Q1 2025 | 492.14K | $1.34M | Hold |
| Q2 2025 | 358.11K | $1.44M | Reduce |
| Q3 2025 | 1.04M | $5.27M | Add |
| Q4 2025 | 1.74M | $8.39M | Add |
| Q1 2026 | 2.82M | $11.77M | Add |
| Q2 2026 | 3.13M | $16.51M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SRTA
- Third Point 5.00M sh · $26.35M · Q2 2026
- BlackRock Inc 4.84M sh · $25.48M · Q2 2026
- Vanguard Group 3.63M sh · $17.48M · Q4 2025
- ARK Invest 2.73M sh · $14.39M · Q2 2026
- First Eagle Investment Management 2.31M sh · $12.20M · Q2 2026
- Geode Capital Management 1.76M sh · $9.25M · Q2 2026
- BNY Mellon 1.14M sh · $6.01M · Q2 2026
- Northern Trust Corp 676.58K sh · $3.57M · Q2 2026
- Citigroup Inc 526.86K sh · $2.78M · Q2 2026
- Renaissance Technologies 492.39K sh · $2.59M · Q2 2026
- Goldman Sachs Group 471.53K sh · $2.48M · Q2 2026